Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001315863-25-000390·AVADEL PHARMACEUTICALS PLC
Schedule 13G ownership disclosure
AVADEL PHARMACEUTICALS PLC
Ordinary Shares, nominal value $0.01 per share · CUSIP: G29687103
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Two Seas Capital LP
Shares: 4,946,449 · Class: 5.1%
- Two Seas Capital GP LLC
Shares: 4,946,449 · Class: 5.1%
- Sina Toussi
Shares: 4,946,449 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001315863-25-000390
- Form type
- SCHEDULE 13G
- Filer
- AVADEL PHARMACEUTICALS PLC
- CIK
- CIK 1012477
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership